Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
midazolam + diazepam + propofol
- Development stage
- Unknown
- Lead developer
- Wei Zhao
- Modality
- Small Molecules
- Administration
- Intravenous
01
Overview
Midazolam + diazepam + propofol refers to the co-administration of these three sedative and anesthetic agents, specifically in the context of a Phase 4 therapeutic drug monitoring (TDM) study in Chinese children led by Wei Zhao. Midazolam and diazepam are benzodiazepines that enhance the activity of the inhibitory neurotransmitter GABA at the GABA-A receptor, providing sedation and anxiolysis. Propofol is an intravenous anesthetic that also acts as a positive allosteric modulator of the GABA-A receptor. The study aims to correlate blood concentrations of these drugs with clinical efficacy and safety to optimize sedation protocols for pediatric patients across different age and gender groups.
- Other names
- Midazolam/diazepam/propofol
02
Targets
GABRR (GABA-A receptor subunit rho)
Beyond the preview
Go deeper on midazolam + diazepam + propofol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on midazolam + diazepam + propofol.